Oncology and Hematology

Episodes 1-16 of 178

• • 

    

    Fortunato Ciardiello, MD, PhD

    Peer

  • 

    

    Erika Martinelli, MD, PhD

    Peer

  0

  

  RestartResume

  Addressing the Challenge in Rechallenge Strategies for mCRC

  RestartResume

  Addressing the Challenge in Rechallenge Strategies for mCRC

  0.25 credits

  Addressing the Challenge in Rechallenge Strategies for mCRC

  0.25 credits

• • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Brian Mulherin, MD

    Peer

  0

  

  RestartResume

  Managing PNH Patients: Addressing the Unmet Needs

  RestartResume

  Managing PNH Patients: Addressing the Unmet Needs

  Managing PNH Patients: Addressing the Unmet Needs

• • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    David Dingli, MD, PhD

    Peer

  0

  

  RestartResume

  Improving PNH Patient Outcomes

  RestartResume

  Improving PNH Patient Outcomes

  Improving PNH Patient Outcomes

• • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Brian Mulherin, MD

    Peer

  0

  

  RestartResume

  Examining the Treatment Paradigm for Paroxysmal Nocturnal Hemoglobinuria

  RestartResume

  Examining the Treatment Paradigm for Paroxysmal Nocturnal Hemoglobinuria

  Examining the Treatment Paradigm for Paroxysmal Nocturnal Hemoglobinuria

• • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Hana Safah, MD

    Peer

  • 

    

    Timothy Kubal, MD

    Peer

  0

  

  RestartResume

  Conquering the Burden & Impacts of PNH

  RestartResume

  Conquering the Burden & Impacts of PNH

  Conquering the Burden & Impacts of PNH

• • 

    

    Alok A. Khorana, MD

    Peer

  2

  

  RestartResume

  Prophylaxis of Medically Treated Patient With Cancer and Reduced Mobility in Hospital

  RestartResume

  Prophylaxis of Medically Treated Patient With Cancer and Reduced Mobility in Hospital

  1.00 program credit

  Prophylaxis of Medically Treated Patient With Cancer and Reduced Mobility in Ho…

  1.00 program credit

• • 

    

    Cihan Ay, MD

    Peer

  • 

    

    Jean M. Connors, MD

    Peer

  • 

    

    Alok A. Khorana, MD

    Peer

  2

  

  1.00 credit 7 episodes

  The CAT is Out of the Bag: Real-World Data & Evidence-Based Medicine - Both…

  1.00 credit 7 episodes

• • 

    

    Alok A. Khorana, MD

    Peer

  2

  

  RestartResume

  Treatment of Patients With Established VTE With Cancer and COVID-19

  RestartResume

  Treatment of Patients With Established VTE With Cancer and COVID-19

  1.00 program credit

  Treatment of Patients With Established VTE With Cancer and COVID-19

  1.00 program credit

• • 

    

    Cihan Ay, MD

    Peer

  4

  

  RestartResume

  Treatment of a Patient With Cancer and With Catheter-Related Thrombosis

  RestartResume

  Treatment of a Patient With Cancer and With Catheter-Related Thrombosis

  1.00 program credit

  Treatment of a Patient With Cancer and With Catheter-Related Thrombosis

  1.00 program credit

• • 

    

    Jean M. Connors, MD

    Peer

  3

  

  RestartResume

  Treatment of Patient With Low Risk of Genitourinary Bleed for Established VTE With Cancer

  RestartResume

  Treatment of Patient With Low Risk of Genitourinary Bleed for Established VTE With Cancer

  1.00 program credit

  Treatment of Patient With Low Risk of Genitourinary Bleed for Established VTE W…

  1.00 program credit

• • 

    

    Jean M. Connors, MD

    Peer

  2

  

  RestartResume

  Treatment of Patient With Low Risk of Gastrointestinal Absorption Impairment for Established VTE With Cancer

  RestartResume

  Treatment of Patient With Low Risk of Gastrointestinal Absorption Impairment for Established VTE With Cancer

  1.00 program credit

  Treatment of Patient With Low Risk of Gastrointestinal Absorption Impairment fo…

  1.00 program credit

• • 

    

    Cihan Ay, MD

    Peer

  • 

    

    Jean M. Connors, MD

    Peer

  • 

    

    Alok A. Khorana, MD

    Peer

  3

  

  RestartResume

  How Do We Make Sense of Guidelines and Apply to Our Everyday Practice?

  RestartResume

  How Do We Make Sense of Guidelines and Apply to Our Everyday Practice?

  1.00 program credit

  How Do We Make Sense of Guidelines and Apply to Our Everyday Practice?

  1.00 program credit

• • 

    

    Cihan Ay, MD

    Peer

  2

  

  RestartResume

  Primary Thromboprophylaxis of Patient at High-Risk of VTE Who Is Receiving Systemic Anticancer Therapy

  RestartResume

  Primary Thromboprophylaxis of Patient at High-Risk of VTE Who Is Receiving Systemic Anticancer Therapy

  1.00 program credit

  Primary Thromboprophylaxis of Patient at High-Risk of VTE Who Is Receiving Syst…

  1.00 program credit

• • 

    

    Hope S. Rugo, MD, FASCO

    Peer

  1

  

  RestartResume

  What Is the Latest Real-World Evidence With CDK4/6 Inhibitors in Metastatic HR+ Breast Cancer?

  RestartResume

  What Is the Latest Real-World Evidence With CDK4/6 Inhibitors in Metastatic HR+ Breast Cancer?

  0.75 program credits

  What Is the Latest Real-World Evidence With CDK4/6 Inhibitors in Metastatic HR+…

  0.75 program credits

• • 

    

    Hope S. Rugo, MD, FASCO

    Peer

  • 

    

    Adam M. Brufsky, MD, PhD

    Peer

  1

  

  RestartResume

  Interpretation and Application of RWE to Inform Shared Decision-Making in Metastatic HR+ Breast Cancer

  RestartResume

  Interpretation and Application of RWE to Inform Shared Decision-Making in Metastatic HR+ Breast Cancer

  0.75 program credits

  Interpretation and Application of RWE to Inform Shared Decision-Making in Metas…

  0.75 program credits

• • 

    

    Hope S. Rugo, MD, FASCO

    Peer

  • 

    

    Adam M. Brufsky, MD, PhD

    Peer

  1

  

  0.75 credits 3 episodes

  Metastatic Breast Cancer: Applying Real-World Evidence to Enhance Shared Decisi…

  0.75 credits 3 episodes

• Prev
• 1
• 2
• 3
• …
• 11
• 12
• Next